SEATTLE — Seattle Children’s Hospital made a landmark announcement Wednesday — the first leukemia patient in the state to try a new cancer therapy is disease free.
On July 10, 2013 Seattle Children’s announced a significant breakthrough in the fight against children’s cancer. A young woman from Bellingham WA. who has been fighting Leukemia for many years is cancer free.
Lynsie Conradi was in her third reoccurrence of Leukemia in her young 23 years. The Leukemia was resistant to Chemo and Radiation leaving Lynsie with a 20% chance of survival. Because of the research done at Seattle Children’s with T-Cell therapy Lynsie is cancer free.
T-Cells are removed from the patient’s body and reprogrammed and placed back in the body. The T-Cells then seek out and destroy the cancer cells, think of Pac Man. After reintroduction of Lynsie’s T-Cells Doctors rechecked her bone marrow 7 days later and found no trace of cancer.
Lynsie is the first patient in Washington to participate in the Phase 1 trials at Seattle Children’s. Dr. Rebecca Gardner is the lead researcher for this trial. Dr. Gardner is a Hematology/Oncology specialist at the Ben Towne research center at Seattle Children’s, she also participated in the Fellowship program at Seattle Children’s.
Kiwanis Children’s Cancer Program, KCCP, is raising money to fund Fellowships at three Pacific Northwest Hospitals, KDCCP at Doernbecher in Portland Oregon, KCCP Seattle Children’s Hospital and KCCP BC Children’s Hospital in Vancouver Canada. Our goal is to fund three fellows at each hospital. As of fiscal year 2012 we have raised over $600,000 between the 3 groups!!
The Pediatric Hematology/Oncology Fellowship program at Seattle Children’s was established in 1969. Fellows receive training and experience in both basic research and clinical research throughout the three years of training. Each fellow has an individualized research program. The available programs at Fred Hutchinson Cancer Research Center, University of Washington and Children’s represent a wide variety of research opportunities. Research projects are tailored to meet the needs of individual fellows depending on their interests, previous training and experience. Dr.’s at Doernbecher and at BC Children’s hospital are also part of this clinical trial and are well on their way to their own breakthroughs with this exciting new treatment.
This is what we are working for, a cure for children’s cancer. This is a first step and we should be proud that KCCP has a part, all be it very small, and we should be encouraged that the program is working and we are on our way to a cure.
With our continued efforts KCCP will continue to raise money to fund fellows at all three hospitals in the Pacific Northwest. These fellows will continue the research started by Dr. Rebecca Gardner and Dr. Michael Jensen and many others. Maybe we will see KCCP in the next breakthrough announcements at one of the three hospitals.